Creating new catalysts for advanced chemical reactions
New precursors for diverse radical reactions enabled by potent photoreductants
['FUNDING_R01'] · UNIVERSITY OF WISCONSIN-MADISON · NIH-11012346
This study is looking at new ways to create special materials that help make important chemicals more easily, which could eventually lead to better medicines for patients.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF WISCONSIN-MADISON (nih funded) |
| Locations | 1 site (MADISON, UNITED STATES) |
| Trial ID | NIH-11012346 on ClinicalTrials.gov |
What this research studies
This research focuses on developing innovative catalysts that can generate radical intermediates through a process called photoredox catalysis. By utilizing electrochemistry, the team aims to create new photocatalysts that can facilitate chemical reactions that are currently difficult to achieve. The project will explore how these catalysts can be used to enhance the synthesis of valuable compounds, which could have applications in drug discovery and other biomedical fields. Patients may benefit indirectly from this research as it could lead to the development of new therapeutic agents.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals with conditions that could be treated by new drugs developed through advanced synthetic methods.
Not a fit: Patients who are not seeking new treatment options or those with conditions unrelated to the therapeutic areas targeted by this research may not benefit.
Why it matters
Potential benefit: If successful, this research could lead to the creation of more effective drugs and treatments for various medical conditions.
How similar studies have performed: Other research in photoredox catalysis has shown promise, indicating that this approach could lead to significant advancements in chemical synthesis.
Where this research is happening
MADISON, UNITED STATES
- UNIVERSITY OF WISCONSIN-MADISON — MADISON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: WICKENS, ZACHARY KIMBLE — UNIVERSITY OF WISCONSIN-MADISON
- Study coordinator: WICKENS, ZACHARY KIMBLE
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.